Senores Pharmaceuticals Limited (NSE:SENORES)
India flag India · Delayed Price · Currency is INR
616.50
+4.35 (0.71%)
Last updated: Jul 15, 2025

Senores Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22
28,20626,278---
Enterprise Value
27,75928,923---
Last Close Price
612.45570.60---
PE Ratio
37.9944.87---
PS Ratio
7.086.60---
PB Ratio
3.473.24---
P/TBV Ratio
4.994.65---
EV/Sales Ratio
6.977.26---
EV/EBITDA Ratio
30.9532.24---
EV/EBIT Ratio
38.1039.70---
Debt / Equity Ratio
0.390.391.111.380.40
Debt / EBITDA Ratio
3.513.516.695.5610.62
Asset Turnover
0.430.430.570.37-
Inventory Turnover
3.853.855.384.19-
Quick Ratio
2.122.120.770.742.31
Current Ratio
3.003.001.010.992.74
Return on Equity (ROE)
11.18%11.18%23.60%20.55%-
Return on Assets (ROA)
4.93%4.93%5.25%7.16%-
Return on Capital (ROIC)
5.63%5.63%6.61%8.54%-
Return on Capital Employed (ROCE)
7.40%7.40%8.40%13.80%2.50%
Earnings Yield
2.08%2.23%---
FCF Yield
-7.21%-7.74%---
Buyback Yield / Dilution
-562.54%-40.98%-103.16%-131.33%-
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.